Literature DB >> 33484475

Sphingosine kinase 1 downregulation is required for adaptation to serine deprivation.

Jean-Philip Truman1,2, Christian F Ruiz3, Magali Trayssac1,2, Cungui Mao1,2, Yusuf A Hannun1,2,4,5, Lina M Obeid1,2,6.   

Abstract

It has been well-established that cancer cells often display altered metabolic profiles, and recent work has concentrated on how cancer cells adapt to serine removal. Serine can be either taken exogenously or synthesized from glucose, and its regulation forms an important mechanism for nutrient integration. One of the several important metabolic roles for serine is in the generation of bioactive sphingolipids since it is the main substrate for serine palmitoyltransferase, the initial and rate-limiting enzyme in the synthesis of sphingolipids. Previously, serine deprivation has been connected to the action of the tumor suppressor p53, and we have previously published on a role for p53 regulating sphingosine kinase 1 (SK1), an enzyme that phosphorylates sphingosine to form sphingosine-1-phosphate (S1P). SK1 is a key enzyme in sphingolipid synthesis that functions in pro-survival and tumor-promoting pathways and whose expression is also often elevated in cancers. Here we show that SK1 was degraded during serine starvation in a time and dose-dependent manner, which led to sphingosine accumulation. This was independent of effects on p53 but required the action of the proteasome. Furthermore, we show that overexpression of SK1, to compensate for SK1 loss, was detrimental to cell growth under conditions of serine starvation, demonstrating that the suppression of SK1 under these conditions is adaptive. Mitochondrial oxygen consumption decreased in response to SK1 degradation, and this was accompanied by an increase in intracellular reactive oxygen species (ROS). Suppression of ROS with N-acteylcysteine resulted in suppression of the metabolic adaptations and in decreased cell growth under serine deprivation. The effects of SK1 suppression on ROS were mimicked by D-erythro-sphingosine, whereas S1P was ineffective, suggesting that the effects of loss of SK1 were due to the accumulation of its substrate sphingosine. This study reveals a new mechanism for regulating SK1 levels and a link of SK1 to serine starvation as well as mitochondrial function.
© 2021 Federation of American Societies for Experimental Biology.

Entities:  

Keywords:  serine; sphingolipids; sphingosine; sphingosine kinase 1

Mesh:

Substances:

Year:  2021        PMID: 33484475      PMCID: PMC8272629          DOI: 10.1096/fj.202001814RR

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  66 in total

1.  The sphingosine kinase 1 inhibitor 2-(p-hydroxyanilino)-4-(p-chlorophenyl)thiazole induces proteasomal degradation of sphingosine kinase 1 in mammalian cells.

Authors:  Carolyn Loveridge; Francesca Tonelli; Tamara Leclercq; Keng Gat Lim; Jaclyn S Long; Evgeny Berdyshev; Rothwelle J Tate; Viswanathan Natarajan; Stuart M Pitson; Nigel J Pyne; Susan Pyne
Journal:  J Biol Chem       Date:  2010-10-06       Impact factor: 5.157

2.  Novel sphingosine-containing analogues selectively inhibit sphingosine kinase (SK) isozymes, induce SK1 proteasomal degradation and reduce DNA synthesis in human pulmonary arterial smooth muscle cells.

Authors:  Hoe-Sup Byun; Susan Pyne; Neil Macritchie; Nigel J Pyne; Robert Bittman
Journal:  Medchemcomm       Date:  2013       Impact factor: 3.597

3.  Requirement for p53 and p21 to sustain G2 arrest after DNA damage.

Authors:  F Bunz; A Dutriaux; C Lengauer; T Waldman; S Zhou; J P Brown; J M Sedivy; K W Kinzler; B Vogelstein
Journal:  Science       Date:  1998-11-20       Impact factor: 47.728

4.  An oncogenic role of sphingosine kinase.

Authors:  P Xia; J R Gamble; L Wang; S M Pitson; P A Moretti; B W Wattenberg; R J D'Andrea; M A Vadas
Journal:  Curr Biol       Date:  2000-11-30       Impact factor: 10.834

5.  Sphingosine kinase-1 expression correlates with poor survival of patients with glioblastoma multiforme: roles of sphingosine kinase isoforms in growth of glioblastoma cell lines.

Authors:  James R Van Brocklyn; Catherine A Jackson; Dennis K Pearl; Mark S Kotur; Pamela J Snyder; Thomas W Prior
Journal:  J Neuropathol Exp Neurol       Date:  2005-08       Impact factor: 3.685

6.  Tumour microenvironment on mitochondrial dynamics and chemoresistance in cancer.

Authors:  Youngjin Han; Untack Cho; Soochi Kim; In Sil Park; Jae Hyun Cho; Danny N Dhanasekaran; Yong Sang Song
Journal:  Free Radic Res       Date:  2018-04-19

7.  Down-regulation of sphingosine kinase-1 by DNA damage: dependence on proteases and p53.

Authors:  Tarek A Taha; Walid Osta; Lina Kozhaya; Jacek Bielawski; Korey R Johnson; William E Gillanders; Ghassan S Dbaibo; Yusuf A Hannun; Lina M Obeid
Journal:  J Biol Chem       Date:  2004-02-26       Impact factor: 5.157

Review 8.  1-Deoxysphingolipids Encountered Exogenously and Made de Novo: Dangerous Mysteries inside an Enigma.

Authors:  Jingjing Duan; Alfred H Merrill
Journal:  J Biol Chem       Date:  2015-05-06       Impact factor: 5.157

9.  Serine catabolism is essential to maintain mitochondrial respiration in mammalian cells.

Authors:  Stephanie Lucas; Guohua Chen; Siddhesh Aras; Jian Wang
Journal:  Life Sci Alliance       Date:  2018-05-21

10.  Serine starvation induces stress and p53-dependent metabolic remodelling in cancer cells.

Authors:  Oliver D K Maddocks; Celia R Berkers; Susan M Mason; Liang Zheng; Karen Blyth; Eyal Gottlieb; Karen H Vousden
Journal:  Nature       Date:  2012-12-16       Impact factor: 49.962

View more
  2 in total

1.  1-Deoxysphinganine initiates adaptive responses to serine and glycine starvation in cancer cells via proteolysis of sphingosine kinase.

Authors:  Jean-Philip Truman; Christian F Ruiz; Emily Montal; Monica Garcia-Barros; Izolda Mileva; Ashley J Snider; Yusuf A Hannun; Lina M Obeid; Cungui Mao
Journal:  J Lipid Res       Date:  2021-11-24       Impact factor: 5.922

Review 2.  A Rheostat of Ceramide and Sphingosine-1-Phosphate as a Determinant of Oxidative Stress-Mediated Kidney Injury.

Authors:  Norishi Ueda
Journal:  Int J Mol Sci       Date:  2022-04-04       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.